Concepedia

Catherine A. Rugg

CA

Statistics

Publications

16

Citations

3.3K

H-Index

16

Active since

1983

Affiliations

Johnson & Johnson (United States)(Current)

Ludwig Cancer Research

The University of Sydney

Ludwig Cancer Research

Catherine A. Rugg is an author at Johnson & Johnson (United States) specializing in medicine, oncology, and molecular oncology.

Publications per year

1983–2014

16

Publications

16

Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

David W. Hedley, Michael Friedländer, Ian W. Taylor et al. · Journal of Histochemistry & Cytochemistry · 1983 · 2.1K citations

, , +17

Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.

David W. Hedley, Catherine A. Rugg, Richard D. Gelber · PubMed · 1987 · 265 citations

, , +14

Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.

David W. Hedley, Catherine A. Rugg, Alan B. P. Ng et al. · PubMed · 1984 · 147 citations

, , +17

1-Acyl-1<i>H</i>-[1,2,4]triazole-3,5-diamine Analogues as Novel and Potent Anticancer Cyclin-Dependent Kinase Inhibitors:  Synthesis and Evaluation of Biological Activities

Ronghui Lin, Peter J. Connolly, Shenlin Huang et al. · Journal of Medicinal Chemistry · 2005 · 128 citations · Full text

, , +13

The <i>In vitro</i> and <i>In vivo</i> Effects of JNJ-7706621: A Dual Inhibitor of Cyclin-Dependent Kinases and Aurora Kinases

Stuart L. Emanuel, Catherine A. Rugg, Robert H. Gruninger et al. · Cancer Research · 2005 · 125 citations · Full text

, , +13

1–5 of 16